#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thymic carcinoma Paget's disease of the vulva Prostate cancer Fragile X syndrome Anaemia ROHHAD syndrome Bronchiectasis Hereditary spastic paraplegia Squamous cell carcinoma of head and neck Lymphoma Small cell lung cancer recurrent Kidney transplant rejection Loss of consciousness Pleomorphic leiomyosarcoma Pseudoxanthoma elasticum More trials…

    Learn about Rare Diseases

    Medulloblastoma recurrent – Diagnostics Mastocytosis – Treatment Loeys-Dietz syndrome – Basic Information Encephalitis autoimmune Congenital generalised lipodystrophy – Basic Information Encephalitis autoimmune – Diagnostics Rett syndrome Lysosomal storage disorder – Life with Disease Testicular leiomyosarcoma – Diagnostics Marfan’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ceralasertib Keto-Valine Calcium Ro7247669 Piperacillin Monohydrate Trehalose Dihydrate (Ph.eur.) ZIGAKIBART Pentoxifylline Avalglucosidase Alfa POLYSORBATE 80 CITRIC ACID ANHYDROUS Mometasone Teprotumumab Fidanacogene Elaparvovec Suvecaltamide Nirogacestat Hydrobromide GSKVX000000046019 Levetiracetam Irbesartan Prednisone Acetate Azithromycin More therapies…

    Learn about Your Condition

    Hypertrophic cardiomyopathy Klinefelter's syndrome Lymphangiosarcoma Trigeminal neuralgia Hepatorenal syndrome Retroperitoneal fibrosis B-cell lymphoma refractory Organ donor Uterine cancer Mixed-type liposarcoma Metachromatic leukodystrophy Anal squamous cell carcinoma Basal cell carcinoma Giardiasis Acquired ATTR amyloidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Factor VIII deficiency

  • Continued Access Study for Patients with Severe Hemophilia A Using Efanesoctocog Alfa

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Efanesoctocog Alfa
    Bulgaria France Germany Greece Italy The Netherlands +4

  • Study on Personalized Dosing of Emicizumab for Patients with Congenital Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Emicizumab
    The Netherlands

  • Study on the Safety and Effects of NXT007 for Patients with Severe or Moderate Hemophilia A

    Recruiting

    1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Ro7589655
    Italy Poland Spain

  • Study on Long-Term Safety and Effects of Marstacimab for Patients with Severe Hemophilia A or B, With or Without Inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Factor IX deficiency
    • Factor VIII deficiency
    Investigated Drugs:
    • Marstacimab
    Austria Croatia Czechia Denmark France Germany +3

  • Study on Marstacimab for Children with Severe Hemophilia A or B, With or Without Inhibitors

    Recruiting

    3 1 1
    Investigated Drugs:
    • Marstacimab
    Austria Czechia Denmark France Germany Italy +2

  • Study on the Use of Simoctocog Alfa and Emicizumab for Surgery in Patients with Severe Hemophilia A

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Simoctocog Alfa
    Croatia Finland France Germany Italy Spain
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!